Larvol Delta - CNS-Pharmaceuticals-to-Present-at-the-Virtual-Investor-Innovations-in-Oncology--Ongoing-Pivotal-Global-Study-for-Treatment-of-Glioblastoma-Multiforme-GBM

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-to-present-at-the-virtual-investor-innovations-in-oncology--ongoing-pivotal-global-study-for-treatment-of-glioblastoma-multiforme-gbm-301631776.html

Sep 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next